# Meditect

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/meditect

- Industry: Healthcare IT
- Headquarters: Bordeaux, France
- Website: www.meditect.com
- Latest round: Seed (May 6, 2020)
- Investors on record: 1

## About

Meditect SAS offers innovative healthcare management solutions focused on enhancing drug safety and operational efficiency in pharmacies and healthcare institutions across sub-Saharan Africa.Founded in 2017 and headquartered in Bordeaux, France, Meditect SAS specializes in healthcare management solutions. The company has undergone no major pivots and does not have any known subsidiaries. It has raised a total of EUR 0.30 mn in funding, with the most recent deal occurring on May 6, 2020, led by Finck Ventures. The firm has completed a total of 2 deals, and the founder, Arnaud Pourredon, has a history of entrepreneurship, leading the company as CEO.Meditect specializes in innovative healthcare management solutions tailored for the French-speaking sub-Saharan African market. Its core offerings include a highly regarded pharmacy management software, the first accredited health product reference database, and a unique solution for ensuring the authenticity and traceability of medications. These products cater to pharmacies, healthcare providers, and patients by enhancing operational efficiency, improving drug safety, and facilitating patient access to open pharmacies and essential medications. The pharmacy management software streamlines pharmacy operations, while the health product reference database provides essential information approved by local authorities. Additionally, Meditect's application for patients helps locate nearby pharmacies and verify medications at no cost, significantly benefiting end-users who may have limited resources. These solutions are actively deployed across various countries within sub-Saharan Africa, addressing critical healthcare challenges in the region.Meditect generates revenue through a mix of subscription-based models and partnerships with healthcare stakeholders. The company establishes relationships with pharmacies and health institutions that utilize its flagship pharmacy management software and health product reference database, fostering a business-to-business (B2B) environment. Revenue is derived from licensing fees for its software as well as from collaborations with organizations focused on improving healthcare access and combating counterfeit medications. The transactional structure involves providing access to the software and databases for a fee, tailored to the needs of individual clients or institutions. As a result, Meditect effectively contributes to the local healthcare ecosystem while addressing the pressing issues of drug safety and accessibility in the region.Looking ahead, Meditect plans to expand its product offerings and geographic presence. The company is focusing on developing new healthcare management solutions aimed at addressing additional needs within the healthcare sector. Furthermore, Meditect has identified opportunities for expansion into new markets across the African continent by late 2023. The recent funding of EUR 0.30 mn raised on May 6, 2020, will be utilized to support these initiatives, enhancing product development and market outreach efforts.

## Funding rounds

- Seed, May 6, 2020 — LBO France

## Investors

- LBO France (https://capitalatlas.ai/funds/lbo-france) — Seed